P. Thevenaz

机构：Novartis (Switzerland)

发表论文 1 篇 · 总被引 5 次 · h-index 1

代表论文

• Everolimus (Afinitor®), Trastuzumab (H), and Paclitaxel (P) or Vinorelbine (V) in the Treatment of HER-2+ Metastatic Breast Cancer (MBC) Patients (Pts) Pre-Treated with Lapatinib-Containing Therapy: Pooled Analysis of 2 Phase I Studies. (2009 · Cancer Research · 被引 5)